Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection-Reference-Cited by-同舟云学术

Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection

Published:2021-08-06 Issue:12 Volume:28 Page:6978-6985
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Broman Kristy K.,Bettampadi Deepti,Pérez-Morales Jaileene,Sun James,Kirichenko Dennis,Carr Michael J.,Eroglu Zeynep,Tarhini Ahmad A.,Khushalani Nikhil,Schabath Matthew B.,Sarnaik Amod,Sondak Vernon K.,Zager Jonathan S.

Funder

H. Lee Moffitt Cancer Center and Research Institute

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10570-5.pdf

Reference21 articles.

1. Svedman FC, Pillas D, Taylor A, Kaur M, Linder R, Hansson J. Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe—a systematic review of the literature. Clin Epidemiol. 2016;8:109–22. https://doi.org/10.2147/CLEP.S99021.

2. Leiter U, Stadler R, Mauch C, et al. Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol. 2019;37(32):3000–8. https://doi.org/10.1200/JCO.18.02306.

3. Kwak M, Farrow NE, Salama AKS, et al. Updates in adjuvant systemic therapy for melanoma. J Surg Oncol. 2019;119(2):222–31. https://doi.org/10.1002/jso.25298.

4. Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757–67. https://doi.org/10.1016/S1470-2045(16)00141-8.

5. Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–22. https://doi.org/10.1056/NEJMoa1613210.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review;Surgical Oncology;2024-06

2. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma;The American Journal of Surgery;2024-05

3. Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years;Journal of Plastic, Reconstructive & Aesthetic Surgery;2024-05

4. An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Surveillance Strategies in Patients with Stage I, II, III or Resectable IV Melanoma Who Were Treated with Curative Intent;Clinical Oncology;2024-04

5. Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report;Cancers;2023-09-01